Indivior PLC (INDV)
36.01
-0.59
(-1.61%)
USD |
NASDAQ |
Dec 09, 16:00
35.99
-0.02
(-0.06%)
After-Hours: 20:00
Indivior EPS Diluted (Quarterly): 0.3256 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viatris, Inc. | -0.1101 |
| Pfizer Inc. | 0.6197 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 42.00M |
| Revenue (Quarterly) | 314.00M |
| Total Expenses (Quarterly) | 272.00M |
| Enterprise Value | 4.413B |
| Gross Profit Margin (Quarterly) | 80.25% |
| Profit Margin (Quarterly) | 13.38% |
| Earnings Yield | 2.79% |
| Operating Earnings Yield | 7.32% |
| Normalized Earnings Yield | 4.458 |